HER2-positive Refractory Advanced Cancer
1 clinical trials · Condition
◉ Watch HER2-positive Refractory Advanced Cancer
| Record | Firm | Date |
|---|---|---|
| Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer (NCT02342587) | Samsung Medical Center | 2014-12-03 |
Track HER2-positive Refractory Advanced Cancer automatically
Every clearance here is in the API, with alerts when new ones post.